FDA real world data enterprise proposal

‘Real world data’ is becoming increasingly important when it comes to developing and reviewing promising new medicines. As this data is collected from a variety of sources outside the narrow, tightly controlled clinical trial setting, [...]

By |2021-03-15T11:09:11+00:00July 19th, 2018|FDA|
Go to Top